Abstract
In 19 infants and children with acute and severe hypertension following a cardiovascular operation urapidil infusion was started for treatment of the hypertensive crisis. In all patients blood pressure was effectively reduced within 15 min. The drop in systemic blood pressure was combined with a reduction of central venous pressure. Heart rate and urine volume remained unaltered. Serum electrolytes after 12-24 h therapy showed a slight but significant decrease in serum sodium and an increase in serum potassium concentration. In one case urapidil treatment had to be interrupted because of hypotension. In this case the urapidil therapy was tolerated later in lower doses. Serious side effects were not observed. In our experience urapidil can be recommended for the treatment of hypertensive crises in children.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
